Correlation Between Collegium Pharmaceutical and Procaps Group

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Collegium Pharmaceutical and Procaps Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Collegium Pharmaceutical and Procaps Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Collegium Pharmaceutical and Procaps Group SA, you can compare the effects of market volatilities on Collegium Pharmaceutical and Procaps Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Collegium Pharmaceutical with a short position of Procaps Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Collegium Pharmaceutical and Procaps Group.

Diversification Opportunities for Collegium Pharmaceutical and Procaps Group

0.88
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Collegium and Procaps is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Collegium Pharmaceutical and Procaps Group SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Procaps Group SA and Collegium Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Collegium Pharmaceutical are associated (or correlated) with Procaps Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Procaps Group SA has no effect on the direction of Collegium Pharmaceutical i.e., Collegium Pharmaceutical and Procaps Group go up and down completely randomly.

Pair Corralation between Collegium Pharmaceutical and Procaps Group

Given the investment horizon of 90 days Collegium Pharmaceutical is expected to generate 0.36 times more return on investment than Procaps Group. However, Collegium Pharmaceutical is 2.75 times less risky than Procaps Group. It trades about 0.04 of its potential returns per unit of risk. Procaps Group SA is currently generating about -0.03 per unit of risk. If you would invest  2,240  in Collegium Pharmaceutical on August 27, 2024 and sell it today you would earn a total of  756.00  from holding Collegium Pharmaceutical or generate 33.75% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Collegium Pharmaceutical  vs.  Procaps Group SA

 Performance 
       Timeline  
Collegium Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Collegium Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's essential indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Procaps Group SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Procaps Group SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Collegium Pharmaceutical and Procaps Group Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Collegium Pharmaceutical and Procaps Group

The main advantage of trading using opposite Collegium Pharmaceutical and Procaps Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Collegium Pharmaceutical position performs unexpectedly, Procaps Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Procaps Group will offset losses from the drop in Procaps Group's long position.
The idea behind Collegium Pharmaceutical and Procaps Group SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities